Cobo, J., Lora-Tamayo, J., Euba, G., Jover-Saenz, A., Palomino, J., del
Toro, M. D., Rodriguez-Pardo, D., Riera, M., Ariza, J., and Red Espanola
para la Investigacion en Patologia, I.: Linezolid in late-chronic prosthetic
joint infection caused by gram-positive bacteria, Diagn. Microbiol. Infect. Dis., 76, 93–98, https://doi.org/10.1016/j.diagmicrobio.2013.02.019, 2013.
Corona, P. S., Espinal, L., Rodriguez-Pardo, D., Pigrau, C., Larrosa, N.,
and Flores, X.: Antibiotic susceptibility in gram-positive chronic joint
arthroplasty infections: increased aminoglycoside resistance rate in
patients with prior aminoglycoside-impregnated cement spacer use, J.
Arthroplasty, 29, 1617–1621, https://doi.org/10.1016/j.arth.2014.03.029, 2014.
de Beaubien, B., Belden, K., Bell, K., Boyle, K., Cordero-Ampuero, J., Della
Valle, C. J., Eijer, H., Ferry, C., Janz, V., Kessler, B., Kratky, A.,
Lachiewicz, A., Martin, K. E., Murillo, O., Nijhof, M., Nodzo, S. R.,
O'Callaghan, M., Petrie, M. J., Stockley, I., and Suleiman, L. I.: Hip and
Knee Section, Treatment, Antimicrobials: Proceedings of International
Consensus on Orthopedic Infections, J. Arthroplasty, 34, S477–S482,
https://doi.org/10.1016/j.arth.2018.09.033, 2019.
Deroche, L., Plouzeau, C., Bemer, P., Tande, D., Valentin, A. S.,
Jolivet-Gougeon, A., Lemarie, C., Bret, L., Kempf, M., Hery-Arnaud, G.,
Corvec, S., Burucoa, C., Arvieux, C., Bernard, L., and and the, C. S. G.:
Probabilistic chemotherapy in knee and hip replacement infection: the place
of linezolid, Eur. J. Clin. Microbiol. Infect. Dis., 38, 1659–1663, https://doi.org/10.1007/s10096-019-03594-z,
2019.
De Vecchi, E., George, D. A., Romano, C. L., Pregliasco, F. E., Mattina, R.,
and Drago, L.: Antibiotic sensitivities of coagulase-negative staphylococci
and Staphylococcus aureus in hip and knee periprosthetic joint infections:
does this differ if patients meet the International Consensus Meeting
Criteria?, Infect. Drug Resist., 11, 539–546, https://doi.org/10.2147/IDR.S151271, 2018.
Drago, L., De Vecchi, E., Bortolin, M., Zagra, L., Romano, C. L., and
Cappelletti, L.: Epidemiology and Antibiotic Resistance of Late Prosthetic
Knee and Hip Infections, J. Arthroplasty, 32, 2496–2500,
https://doi.org/10.1016/j.arth.2017.03.005, 2017.
Edelstein, A. I., Okroj, K. T., Rogers, T., Della Valle, C. J., and Sporer,
S. M.: Systemic Absorption of Antibiotics From Antibiotic-Loaded Cement
Spacers for the Treatment of Periprosthetic Joint Infection, J. Arthroplasty,
33, 835–839, https://doi.org/10.1016/j.arth.2017.09.043, 2018.
Eriksson, H. K., Ahadpour, D., Hailer, N. P., Lazarinis, S., and Jarhult, J.
D.: Linezolid in the treatment of periprosthetic joint infection caused by
coagulase-negative staphylococci, Infect. Dis. (Lond.), 51, 683–690,
https://doi.org/10.1080/23744235.2019.1642510, 2019.
Gandelman, K., Zhu, T., Fahmi, O. A., Glue, P., Lian, K., Obach, R. S., and
Damle, B.: Unexpected effect of rifampin on the pharmacokinetics of
linezolid: in silico and in vitro approaches to explain its mechanism, J. Clin. Pharmacol., 51, 229–236, https://doi.org/10.1177/0091270010366445, 2011.
George, J., Newman, J. M., Klika, A. K., Miller, E. M., Tan, T. L., Parvizi,
J., and Higuera, C. A.: Changes in Antibiotic Susceptibility of
Staphylococcus aureus Between the Stages of 2-Stage Revision Arthroplasty, J.
Arthroplasty, 33, 1844–1849, https://doi.org/10.1016/j.arth.2018.01.056, 2018.
Gomez, J., Canovas, E., Banos, V., Martinez, L., Garcia, E.,
Hernandez-Torres, A., Canteras, M., Ruiz, J., Medina, M., Martinez, P.,
Canovas, A., Soriano, A., and Clavel, M.: Linezolid plus rifampin as a
salvage therapy in prosthetic joint infections treated without removing the
implant, Antimicrob. Agents Chemother., 55, 4308–4310, https://doi.org/10.1128/AAC.00352-11,
2011.
Harwood, P. J., Talbot, C., Dimoutsos, M., Sunderland, G., Shaw, D., Wilcox,
M. H., and Giannoudis, P. V.: Early experience with linezolid for infections
in orthopaedics, Injury, 37, 818–826, https://doi.org/10.1016/j.injury.2006.02.007, 2006.
Hipfl, C., Winkler, T., Janz, V., Perka, C., and Muller, M.: Management of
Chronically Infected Total Knee Arthroplasty With Severe Bone Loss Using
Static Spacers With Intramedullary Rods, J. Arthroplasty, 34, 1462–1469,
https://doi.org/10.1016/j.arth.2019.03.053, 2019.
Joel, J., Graham, S. M., Peckham-Cooper, A., Korres, N., Tsouchnica, H., and
Tsiridis, E.: Clinical results of linezolid in arthroplasty and trauma MRSA
related infections, World J. Orthop., 5, 151–157, https://doi.org/10.5312/wjo.v5.i2.151, 2014.
Khan, N., Parmar, D., Ibrahim, M. S., Kayani, B., and Haddad, F. S.:
Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint
infection, Bone Joint J., 101-B, 110–115,
https://doi.org/10.1302/0301-620X.101B6.BJJ-2018-1556.R1, 2019.
Kheir, M. M., Tan, T. L., Gomez, M. M., Chen, A. F., and Parvizi, J.:
Patients With Failed Prior Two-Stage Exchange Have Poor Outcomes After
Further Surgical Intervention, J. Arthroplasty, 32, 1262–1265,
https://doi.org/10.1016/j.arth.2016.10.008, 2017.
Kutscha-Lissberg, F., Hebler, U., Muhr, G., and Koller, M.: Linezolid
penetration into bone and joint tissues infected with methicillin-resistant
staphylococci, Antimicrob. Agents Chemother., 47, 3964–3966,
https://doi.org/10.1128/aac.47.12.3964-3966.2003, 2003.
Legout, L., Valette, M., Dezeque, H., Nguyen, S., Lemaire, X., Loiez, C.,
Caillaux, M., Beltrand, E., Dubreuil, L., Yazdanpanah, Y., Migaud, H., and
Senneville, E.: Tolerability of prolonged linezolid therapy in bone and
joint infection: protective effect of rifampicin on the occurrence of
anaemia?, J. Antimicrob. Chemother., 65, 2224–2230, https://doi.org/10.1093/jac/dkq281, 2010.
Leijtens, B., Weerwag, L., Schreurs, B. W., Kullberg, B. J., and Rijnen, W.:
Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a
Prosthetic Joint Infection after Hip Replacement, J. Bone Jt. Infect., 4,
268–276, https://doi.org/10.7150/jbji.37262, 2019.
Lourtet-Hascoet, J., Felice, M. P., Bicart-See, A., Bouige, A., Giordano,
G., and Bonnet, E.: Species and antimicrobial susceptibility testing of
coagulase-negative staphylococci in periprosthetic joint infections,
Epidemiol. Infect., 146, 1771–1776, https://doi.org/10.1017/S0950268818001437, 2018.
Lu, P. L., Wang, J. T., Chen, C. J., Chen, W. C., Chen, T. C., Hwang, Y. C.,
and Chang, S. C.: Compassionate use of linezolid for adult Taiwanese
patients with bone and joint infections, Chemotherapy, 56, 429–435,
https://doi.org/10.1159/000317752, 2010.
Metsemakers, W. J., Kuehl, R., Moriarty, T. F., Richards, R. G., Verhofstad,
M. H. J., Borens, O., Kates, S., and Morgenstern, M.: Infection after
fracture fixation: Current surgical and microbiological concepts, Injury,
49, 511–522, https://doi.org/10.1016/j.injury.2016.09.019, 2018.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., and Group, P.:
Preferred reporting items for systematic reviews and meta-analyses: the
PRISMA statement, PLoS Med., 6, e1000097, https://doi.org/10.1371/journal.pmed.1000097, 2009.
Morata, L., Senneville, E., Bernard, L., Nguyen, S., Buzele, R., Druon, J.,
Tornero, E., Mensa, J., and Soriano, A.: A Retrospective Review of the
Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic
Joint Infections Treated with Debridement and Implant Retention, Infect. Dis.
Ther., 3, 235–243, https://doi.org/10.1007/s40121-014-0032-z, 2014a.
Morata, L., Tornero, E., Martinez-Pastor, J. C., Garcia-Ramiro, S., Mensa,
J., and Soriano, A.: Clinical experience with linezolid for the treatment of
orthopaedic implant infections, J. Antimicrob. Chemother., 69 (Suppl. 1), i47–52,
https://doi.org/10.1093/jac/dku252, 2014b.
Moriarty, T. F., Kuehl, R., Coenye, T., Metsemakers, W. J., Morgenstern, M.,
Schwarz, E. M., Riool, M., Zaat, S. A. J., Khana, N., Kates, S. L., and
Richards, R. G.: Orthopaedic device-related infection: current and future
interventions for improved prevention and treatment, EFORT Open Rev., 1,
89–99, https://doi.org/10.1302/2058-5241.1.000037, 2016.
Nguyen, S., Pasquet, A., Legout, L., Beltrand, E., Dubreuil, L., Migaud, H.,
Yazdanpanah, Y., and Senneville, E.: Efficacy and tolerance of
rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in
prolonged oral therapy for bone and joint infections, Clin. Microbiol. Infect.,
15, 1163–1169, https://doi.org/10.1111/j.1469-0691.2009.02761.x, 2009.
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W.,
Steckelberg, J. M., Rao, N., Hanssen, A., Wilson, W. R., and Infectious Diseases Society of America: Executive summary: diagnosis and management of
prosthetic joint infection: clinical practice guidelines by the Infectious
Diseases Societ
y of America, Clinical infectious diseases: an official
publication of the Infectious Diseases Society of America, 56, 1–10,
https://doi.org/10.1093/cid/cis966, 2013a.
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W.,
Steckelberg, J. M., Rao, N., Hanssen, A., Wilson, W. R., and Infectious Diseases Society of America: Diagnosis and management of prosthetic joint
infection: clinical practice guidelines by the Infectious Diseases Society
of America, Clin. Infect. Dis., 56, e1–e25, https://doi.org/10.1093/cid/cis803, 2013b.
Oussedik, S. I. and Haddad, F. S.: The use of linezolid in the treatment of
infected total joint arthroplasty, J. Arthroplasty, 23, 273–278,
https://doi.org/10.1016/j.arth.2007.03.022, 2008.
Papadopoulos, A., Plachouras, D., Giannitsioti, E., Poulakou, G.,
Giamarellou, H., and Kanellakopoulou, K.: Efficacy and tolerability of
linezolid in chronic osteomyelitis and prosthetic joint infections: a
case-control study, J. Chemother., 21, 165–169, https://doi.org/10.1179/joc.2009.21.2.165,
2009.
Parvizi, J., Tan, T. L., Goswami, K., Higuera, C., Della Valle, C., Chen, A.
F., and Shohat, N.: The 2018 Definition of Periprosthetic Hip and Knee
Infection: An Evidence-Based and Validated Criteria, J. Arthroplasty, 33,
1309–1314, https://doi.org/10.1016/j.arth.2018.02.078, 2018.
Pea, F., Furlanut, M., Cojutti, P., Cristini, F., Zamparini, E., Franceschi,
L., and Viale, P.: Therapeutic drug monitoring of linezolid: a retrospective
monocentric analysis, Antimicrob. Agents Chemother., 54, 4605–4610,
https://doi.org/10.1128/AAC.00177-10, 2010.
Pea, F., Viale, P., Cojutti, P., Del Pin, B., Zamparini, E., and Furlanut,
M.: Therapeutic drug monitoring may improve safety outcomes of long-term
treatment with linezolid in adult patients, J. Antimicrob. Chemother., 67,
2034–2042, https://doi.org/10.1093/jac/dks153, 2012.
Rao, N. and Hamilton, C. W.: Efficacy and safety of linezolid for
Gram-positive orthopedic infections: a prospective case series, Diagn. Microbiol. Infect. Dis., 59, 173–179, https://doi.org/10.1016/j.diagmicrobio.2007.04.006, 2007.
Razonable, R. R., Osmon, D. R., and Steckelberg, J. M.: Linezolid therapy
for orthopedic infections, Mayo. Clin. Proc., 79, 1137–1144, https://doi.org/10.4065/79.9.1137,
2004.
Sendi, P. and Zimmerli, W.: Antimicrobial treatment concepts for
orthopaedic device-related infection, Clin. Microbiol. Infect., 18, 1176–1184,
https://doi.org/10.1111/1469-0691.12003, 2012.
Signore, A., Sconfienza, L. M., Borens, O., Glaudemans, A.,
Cassar-Pullicino, V., Trampuz, A., Winkler, H., Gheysens, O., Vanhoenacker,
F., Petrosillo, N., and Jutte, P. C.: Consensus document for the diagnosis
of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR
(with ESCMID endorsement), Eur. J. Nucl. Med. Mol. Imaging, 46, 971–988,
https://doi.org/10.1007/s00259-019-4263-9, 2019.
Siqueira, M. B., Saleh, A., Klika, A. K., O'Rourke, C., Schmitt, S.,
Higuera, C. A., and Barsoum, W. K.: Chronic Suppression of Periprosthetic
Joint Infections with Oral Antibiotics Increases Infection-Free
Survivorship, J. Bone Joint Surg. Am., 97, 1220–1232, https://doi.org/10.2106/JBJS.N.00999,
2015.
Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., and Chipponi,
J.: Methodological index for non-randomized studies (minors): development
and validation of a new instrument, ANZ J. Surg., 73, 712–716,
https://doi.org/10.1046/j.1445-2197.2003.02748.x, 2003.
Soriano, A., Gomez, J., Gomez, L., Azanza, J. R., Perez, R., Romero, F.,
Pons, M., Bella, F., Velasco, M., and Mensa, J.: Efficacy and tolerability
of prolonged linezolid therapy in the treatment of orthopedic implant
infections, Eur. J. Clin. Microbiol. Infect. Dis., 26, 353–356,
https://doi.org/10.1007/s10096-007-0289-1, 2007.
Takoudju, E., Bemer, P., Touchais, S., Asseray, N., Corvec, S.,
Khatchatourian, L., Serandour, N., Boutoille, D., Nantes Bone and Joint Infections Study Group: Bacteriological relevance of linezolid vs. vancomycin
in postoperative empirical treatment of osteoarticular infections: a
retrospective single-center study, Int. J. Antimicrob. Agents, 52, 663–666,
https://doi.org/10.1016/j.ijantimicag.2018.04.022, 2018.
Tattevin, P., Arvieux, C., and Michelet, C.: What is the place of
teicoplanin and linezolid in the treatment of prosthetic joint infections?,
Clin. Microbiol. Infect., 12, 1241–1242, https://doi.org/10.1111/j.1469-0691.2006.01560.x,
2006.
Tevell, S., Baig, S., Nilsdotter-Augustinsson, A., Stegger, M., and
Soderquist, B.: Same Organism, Different Phenotype – Are Phenotypic Criteria
Adequate In Coagulase-Negative Staphylococcal Orthopaedic Implant-Associated
Infections?, J. Bone Jt. Infect., 4, 16–19, https://doi.org/10.7150/jbji.30256, 2019.
Thompson, J. M., Saini, V., Ashbaugh, A. G., Miller, R. J., Ordonez, A. A.,
Ortines, R. V., Wang, Y., Sterling, R. S., Jain, S. K., and Miller, L. S.:
Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other
Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model, J.
Bone Joint Surg. Am., 99, 656–665, https://doi.org/10.2106/JBJS.16.01002, 2017.
Tornero, E., Morata, L., Martinez-Pastor, J. C., Angulo, S., Combalia, A.,
Bori, G., Garcia-Ramiro, S., Bosch, J., Mensa, J., and Soriano, A.:
Importance of selection and duration of antibiotic regimen in prosthetic
joint infections treated with debridement and implant retention, J. Antimicrob. Chemother., 71, 1395–1401, https://doi.org/10.1093/jac/dkv481, 2016.
Vazquez, J. A., Arnold, A. C., Swanson, R. N., Biswas, P., and Bassetti, M.:
Safety of long-term use of linezolid: results of an open-label study, Ther.
Clin. Risk Manag., 12, 1347–1354, https://doi.org/10.2147/TCRM.S109444, 2016.
Winkler, T., Stuhlert, M. G. W., Lieb, E., Muller, M., von Roth, P.,
Preininger, B., Trampuz, A., and Perka, C. F.: Outcome of short versus long
interval in two-stage exchange for periprosthetic joint infection: a
prospective cohort study, Arch. Orthop. Trauma Surg., 139, 295–303,
https://doi.org/10.1007/s00402-018-3052-4, 2019.
Wouthuyzen-Bakker, M., Nijman, J. M., Kampinga, G. A., van Assen, S., and
Jutte, P. C.: Efficacy of Antibiotic Suppressive Therapy in Patients with a
Prosthetic Joint Infection, J. Bone Jt. Infect., 2, 77–83, https://doi.org/10.7150/jbji.17353,
2017.
Zimmerli, W. and Sendi, P.: Role of Rifampin against Staphylococcal Biofilm
Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related
Infections, Antimicrob. Agents Chemother., 63, e01746-18, https://doi.org/10.1128/AAC.01746-18, 2019.
